Shr loss 1.77 dlrs v profit 15 ct Net loss 8,036,000 v profit 576,000 Sales 16.2 mln v 17.2 mln Avg shrs 4,539,437 v 3,816,580 1st half Shr loss 1.96 dlrs v profit 26 ct Net loss 8,231,000 v profit 996,000 Sales 30.9 mln v 32.2 mln Avg shrs 4,205,707 v 3,814,141 NOTE : Current half net includes 68,000 dlr tax credit .
Current year net period includes 6,700,000 dlr writedown inventory clinical chemistry product .
Reuter & # 3 ; 